Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Liver Int ; 44(7): 1680-1688, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38554045

ABSTRACT

BACKGROUND AND AIMS: Systemic mastocytosis (SM) is characterized by the accumulation of atypical mast cells (MCs) in organs. Liver histology of SM has been marginally described and accurate histological classification is critical, given the consequences of aggressive SM diagnosis. We aimed to describe the histological features associated with liver SM using updated tools. METHODS: Using the database of the French Reference Centre for Mastocytosis, we retrospectively identified patients with a liver biopsy (LB) and a diagnosis of SM. All LB procedures were performed according to the local physician in charge and centrally reviewed by an expert pathologist. RESULTS: A total of 28 patients were included: 6 had indolent SM, 9 had aggressive SM, and 13 had SM with an associated hematologic neoplasm. Twenty-five (89%) patients presented hepatomegaly, and 19 (68%) had portal hypertension. The LB frequently showed slight sinusoid dilatation (82%). Fibrosis was observed in 3/6 indolent SM and in almost all advanced SM cases (21/22), but none of them showed cirrhosis. A high MC burden (>50 MCs/high-power field) was correlated with elevated blood alkaline phosphatase levels (p = .030). The presence of portal hypertension was associated with a higher mean fibrosis grade (1.6 vs. 0.8 in its absence; p = .026). In advanced SM, the presence of nodular regenerative hyperplasia (NRH) was associated with decreased overall survival (9.5 vs. 46.3 months, p = .002). CONCLUSIONS: MC infiltration induced polymorphic hepatic lesions and the degree of fibrosis is associated with portal hypertension. NRH identifies a poor prognosis subgroup of patients with advanced SM. Assessing liver histology can aid in SM prognostic evaluation.


Subject(s)
Hepatomegaly , Liver , Mastocytosis, Systemic , Humans , Mastocytosis, Systemic/pathology , Mastocytosis, Systemic/complications , Retrospective Studies , Female , Liver/pathology , Male , Middle Aged , Adult , Biopsy , Hepatomegaly/pathology , Hepatomegaly/etiology , Aged , Hypertension, Portal/pathology , Hypertension, Portal/etiology , France , Liver Cirrhosis/pathology , Mast Cells/pathology , Alkaline Phosphatase/blood , Prognosis
2.
Br J Haematol ; 200(2): 249-255, 2023 01.
Article in English | MEDLINE | ID: mdl-36177683

ABSTRACT

Erythrocytosis is associated with increased red blood cell mass and can be either congenital or acquired. Congenital secondary causes are rare and include germline variants increasing haemoglobin (Hb)-oxygen affinity (e.g., Hb or bisphosphoglycerate mutase (BPGM) variants) or affecting oxygen-sensing pathway proteins. Here, we describe five adults from three kindreds with erythrocytosis associated with heterozygosity for BPGM variants, including one novel. Functional analyses showed partial BPGM deficiency, reduced 2,3-bisphosphoglycerate levels and/or increased Hb-oxygen affinity. We also review currently known BPGM variants. This study contributes to raising awareness of BPGM variants, and in particular that heterozygosity for BPGM deficiency may already manifest clinically.


Subject(s)
Anemia, Hemolytic , Metabolism, Inborn Errors , Polycythemia , Adult , Humans , Bisphosphoglycerate Mutase/genetics , Polycythemia/congenital , Heterozygote , Hemoglobins , Oxygen
SELECTION OF CITATIONS
SEARCH DETAIL
...